Close

MannKind (MNKD) To Present Positive Data for AFREZZA in Patients with Type 2 Diabetes

June 29, 2010 6:52 AM EDT Send to a Friend
AFREZZA (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login